Commerce Minister Piyush Goyal to Visit Switzerland (June 12‑13, 2026) – Focus on TEPA Implementation and India‑Switzerland Trade

Overview The Union Minister of Commerce & Industry, Shri Piyush Goyal will travel to Berne, Switzerland on 12 June 2026 for high‑level talks with Swiss officials and leaders of the Swiss pharmaceutical sector. The visit aims to deepen the India‑Switzerland economic partnership and to push forward the implementation of the Trade and Economic Partnership Agreement (TEPA) . Key Developments Meetings with Ms. Helene Budliger Artieda and Mr. Guy Parmelin . Engagement with senior executives of the Swiss pharmaceutical industry to explore market access under TEPA. Side meetings in Zurich with Swiss companies and investors to discuss expanding bilateral trade and investment. Accompanied by officials from the Department for Promotion of Industry and Internal Trade (DPIIT) and the Ministry of Health and Family Welfare. Important Facts India and the four EFTA members signed TEPA in March 2024; the pact entered into force in October 2025. TEPA provides a comprehensive framework for reducing tariffs, easing services restrictions and encouraging investment flows. The minister’s visit is the first high‑level engagement after the agreement became operational. UPSC Relevance Understanding TEPA helps aspirants grasp India’s strategy of diversifying trade partners beyond traditional markets. The agreement illustrates the use of bilateral and regional trade pacts to boost exports, attract FDI, and integrate Indian industries (especially pharmaceuticals) into global value chains – a recurring theme in GS 3: Economy . The role of ministries such as Commerce & Industry and DPIIT showcases inter‑ministerial coordination, relevant for GS 2: Polity . Moreover, the engagement with Switzerland, a high‑tech economy, reflects India’s focus on technology‑led growth, a point often examined in the GS 3 syllabus. Way Forward Post‑visit, the ministries are expected to: Address operational issues identified during TEPA implementation, such as customs procedures and regulatory alignment. Facilitate sector‑specific dialogues, especially in pharmaceuticals, to unlock market access for Indian firms. Promote joint ventures and investment projects, leveraging Swiss expertise in high‑value manufacturing. Monitor trade data to assess the impact of TEPA on bilateral trade volumes and adjust policy measures accordingly. These steps will help translate the agreement from paper to tangible economic gains for both sides.